Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 2.7.11.19 - phosphorylase kinase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Acidosis, Lactic
Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study.
Acute Kidney Injury
Enhanced proteolytic activity--cause of protein catabolism in acute renal failure.
Evidence for the participation of proteases on protein catabolism during hypercatabolic renal failure.
In vitro inhibition of protein catabolism by alpha 2-macroglobulin in plasma from a patient with posttraumatic acute renal failure.
Alzheimer Disease
Phosphoprotein phosphatase activities in Alzheimer disease brain.
Bradycardia
Fetal bradycardia at 28 weeks of gestation associated with cardiac glycogen phosphorylase b kinase deficiency.
carboxypeptidase t deficiency
Metabolic causes of myoglobinuria.
Carcinoma, Hepatocellular
Glycogen storage in a hepatoma: dephosphophosphorylase kinase defect.
Salt-inducible Kinase 3 Signaling Is Important for the Gluconeogenic Programs in Mouse Hepatocytes.
Cardiomyopathies
Infantile hypertrophic cardiomyopathy of glycogenosis type IX: isolated cardiac phosphorylase kinase deficiency.
Cardiomyopathy, Hypertrophic
Fatal infantile hypertrophic cardiomyopathy secondary to deficiency of heart specific phosphorylase b kinase.
Infantile hypertrophic cardiomyopathy of glycogenosis type IX: isolated cardiac phosphorylase kinase deficiency.
Colorectal Neoplasms
Phosphorylase kinase ? affects colorectal cancer cell growth and represents a novel prognostic biomarker.
Cystic Fibrosis
Peptide microarray analysis of substrate specificity of the transmembrane Ser/Thr kinase KPI-2 reveals reactivity with cystic fibrosis transmembrane conductance regulator and phosphorylase.
Diabetes Mellitus, Type 2
An evaluation of indirubin analogues as phosphorylase kinase inhibitors.
Kinetics, in silico docking, molecular dynamics, and MM-GBSA binding studies on prototype indirubins, KT5720, and staurosporine as phosphorylase kinase ATP-binding site inhibitors: The role of water molecules examined.
Kinetics, in silico docking, molecular dynamics, and MM-GBSA binding studies on prototype indirubins, KT5720, and staurosporine as phosphorylase kinase ATP-binding site inhibitors: the role of water molecules examined.
Fanconi Syndrome
A mutation in GLUT2, not in phosphorylase kinase subunits, in hepato-renal glycogenosis with Fanconi syndrome and low phosphorylase kinase activity.
glycogen phosphorylase deficiency
Genetic deficiencies of the glycogen phosphorylase system.
Glycogen Storage Disease
3D mapping of glycogenosis-causing mutations in the large regulatory alpha subunit of phosphorylase kinase.
A mutation in GLUT2, not in phosphorylase kinase subunits, in hepato-renal glycogenosis with Fanconi syndrome and low phosphorylase kinase activity.
A new type of glycogen storage disease caused by deficiency of cardiac phosphorylase kinase.
A novel PHKA2 gross deletion mutation in a Korean patient with X-linked liver glycogenosis type I.
A novel PHKA2 mutation in a Chinese child with glycogen storage disease type IXa: a case report and literature review.
An evaluation of indirubin analogues as phosphorylase kinase inhibitors.
An unusual case of recurrent episodes of muscle weakness: Co-occurrence of Andersen-Tawil syndrome and glycogen storage disease type IXd.
Autosomal glycogenosis of liver and muscle due to phosphorylase kinase deficiency is caused by mutations in the phosphorylase kinase beta subunit (PHKB).
cDNA cloning of a liver isoform of the phosphorylase kinase alpha subunit and mapping of the gene to Xp22.2-p22.1, the region of human X-linked liver glycogenosis.
Characterization of liver GSD IX ?2 pathophysiology in a novel Phkg2-/- mouse model.
Clinical and laboratory observations in a child with hepatic phosphorylase kinase deficiency.
Clinical, Biochemical, and Genetic Characterization of Glycogen Storage Type IX in a Child with Asymptomatic Hepatomegaly.
Detection of glycogen in a glycogen storage disease by 13C nuclear magnetic resonance.
Families with X-linked liver glycogenosis due to phosphorylase kinase deficiency.
Fanconi's syndrome with hepatorenal glycogenosis associated with phosphorylase b kinase deficiency.
Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency.
Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase.
Fatal infantile glycogen storage disease: deficiency of phosphofructokinase and phosphorylase b kinase.
Fatal infantile hypertrophic cardiomyopathy secondary to deficiency of heart specific phosphorylase b kinase.
Genetic deficiencies of the glycogen phosphorylase system.
Glycogen phosphorylase and its converter enzymes in haemolysates of normal human subjects and of patients with type VI glycogen-storage disease. A study of phosphorylase kinase deficiency.
Glycogen storage disease confined to the heart with deficient activity of cardiac phosphorylase kinase: a new type of glycogen storage disease.
Glycogen storage disease type IX: benign glycogenosis of liver and hepatic phosphorylase kinase deficiency.
Glycogen storage disease type IX: High variability in clinical phenotype.
Glycogen storage disease. Studies related to the mechanism of glycogenosome formation.
Glycogenosis due to liver and muscle phosphorylase kinase deficiency.
Human cDNA encoding the muscle isoform of the phosphorylase kinase gamma subunit (PHKG1).
Human muscle glycogenosis due to phosphorylase kinase deficiency associated with a nonsense mutation in the muscle isoform of the alpha subunit.
Identification of Alu-mediated, large deletion-spanning introns 19-26 in PHKA2 in a patient with X-linked liver glycogenosis (hepatic phosphorylase kinase deficiency).
In situ 13C NMR quantification of hepatic glycogen.
Infantile hypertrophic cardiomyopathy of glycogenosis type IX: isolated cardiac phosphorylase kinase deficiency.
Isolation of cDNA encoding the human liver phosphorylase kinase alpha subunit (PHKA2) and identification of a missense mutation of the PHKA2 gene in a family with liver phosphorylase kinase deficiency.
Liver glycogenosis and phosphorylase kinase deficiency.
Liver glycogenosis due to phosphorylase kinase deficiency: PHKG2 gene structure and mutations associated with cirrhosis.
Localization of a new type of X-linked liver glycogenosis to the chromosomal region Xp22 containing the liver alpha-subunit of phosphorylase kinase (PHKA2).
Loss of cyclic 3'5'-AMP dependent kinase and reduction of phosphorylase kinase in skeletal muscle of a girl with deactivated phosphorylase and glycogenosis of liver and muscle.
Mapping of the gene for X-linked liver glycogenosis due to phosphorylase kinase deficiency to human chromosome region Xp22.
Metabolic myopathies.
Molecular diagnosis of glycogen storage disease type IX using a glycogen storage disease gene panel.
Molecular genetics of phosphorylase kinase: cDNA cloning, chromosomal mapping and isoform structure.
Muscle glycogenosis with low phosphorylase kinase activity: mutations in PHKA1, PHKG1 or six other candidate genes explain only a minority of cases.
Muscle phosphorylase kinase deficiency: a neutral metabolic variant or a disease?
Mutation hotspots in the PHKA2 gene in X-linked liver glycogenosis due to phosphorylase kinase deficiency with atypical activity in blood cells (XLG2).
Mutations in the phosphorylase kinase gene PHKA2 are responsible for X-linked liver glycogen storage disease.
Mutations in the testis/liver isoform of the phosphorylase kinase gamma subunit (PHKG2) cause autosomal liver glycogenosis in the gsd rat and in humans.
Myopathy due to glycogen storage disease: pathological and biochemical studies in relation to glycogenosome formation.
Novel mutations in PHKA2 gene in glycogen storage disease type IX patients from Hong Kong, China.
Novel PHKG2 mutation causing GSD IX with prominent liver disease: report of three cases and review of literature.
PHKG2 mutation spectrum in glycogen storage disease type IXc: a case report and review of the literature.
Phosphorylase b kinase deficiency glycogenosis with cirrhosis of the liver.
Phosphorylase b kinase deficiency in a boy with glycogenosis affecting both liver and muscle.
Phosphorylase b kinase deficiency in glycogenosis type VIII: differentiation of different phenotypes and heterozygotes by erythrocyte enzyme assay.
Phosphorylase kinase deficiency in I-strain mice is associated with a frameshift mutation in the alpha subunit muscle isoform.
Phosphorylase kinase deficiency: severe glycogen storage disease with evidence of autosomal recessive mode of inheritance.
Phosphorylase kinase deficient liver glycogenosis: progression to cirrhosis in infancy associated with PHKG2 mutations (H144Y and L225R)
Phosphorylase kinase in leukocytes and erythrocytes of a patient with glycogen storage disease type IX.
Phosphorylase-kinase-deficient liver glycogenosis with an unusual biochemical phenotype in blood cells associated with a missense mutation in the beta subunit gene (PHKB).
Regional mapping of a liver alpha-subunit gene of phosphorylase kinase (PHKA) to the distal region of human chromosome Xp.
The behavior of hepatic phosphorylase b kinase, phosphorylase a and b after administration of glucagon to patients with glycogen storage disease type VIa.
The natural history of liver glycogenosis due to phosphorylase kinase deficiency: a longitudinal study of 41 patients.
Unequal homologous recombination between LINE-1 elements as a mutational mechanism in human genetic disease.
Variability of biochemical and clinical phenotype in X-linked liver glycogenosis with mutations in the phosphorylase kinase PHKA2 gene.
Variability of clinical and biochemical phenotype in liver phosphorylase kinase deficiency with variants in the phosphorylase kinase (PHKG2) gene.
Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene.
X-chromosomal inheritance of liver glycogenosis with phosphorylase kinase deficiency.
X-linked liver glycogenosis type II (XLG II) is caused by mutations in PHKA2, the gene encoding the liver alpha subunit of phosphorylase kinase.
X-linked liver glycogenosis: localization and isolation of a candidate gene.
[A case of glycogen storage myopathy with acute heart failure]
[Genetic heterogeneity and the diagnosis of hepatic glycogenoses]
[Molecular pathology of hepatic glycogen storage disease]
Glycogen Storage Disease Type II
Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form.
X-linked liver glycogenosis type II (XLG II) is caused by mutations in PHKA2, the gene encoding the liver alpha subunit of phosphorylase kinase.
Glycogen Storage Disease Type IV
Glycogen storage disease. Studies related to the mechanism of glycogenosome formation.
Glycogen Storage Disease Type V
Genetic deficiencies of the glycogen phosphorylase system.
Substrate kinetics in patients with disorders of skeletal muscle metabolism.
Hepatomegaly
Adult phosphorylase b kinase deficiency.
Clinical and Molecular Variability in Patients with PHKA2 Variants and Liver Phosphorylase b Kinase Deficiency.
Discovery of a Genetic Metabolic Cause for Mauriac Syndrome in Type 1 Diabetes.
Uncooked cornstarch treatment for hepatic phosphorylase kinase deficiency.
Variability of clinical and biochemical phenotype in liver phosphorylase kinase deficiency with variants in the phosphorylase kinase (PHKG2) gene.
Hyperlipidemias
Clinical and Molecular Variability in Patients with PHKA2 Variants and Liver Phosphorylase b Kinase Deficiency.
Hyperthyroidism
Mechanisms of enhanced phosphorylase activation in the hyperthyroid rat heart.
Hypoglycemia
Clinical and Molecular Variability in Patients with PHKA2 Variants and Liver Phosphorylase b Kinase Deficiency.
PHKA2 variants expand the phenotype of phosphorylase B kinase deficiency to include patients with ketotic hypoglycemia only.
Phosphorylase b kinase deficiency glycogenosis with cirrhosis of the liver.
Severe phenotype of phosphorylase kinase-deficient liver glycogenosis with mutations in the PHKG2 gene.
Hypothyroidism
Phosphorylase a formation in protein-glycogen particles isolated from fast-twitch muscle of euthyroid and hypothyroid rats.
Liver Cirrhosis
Severe phenotype of phosphorylase kinase-deficient liver glycogenosis with mutations in the PHKG2 gene.
Variability of clinical and biochemical phenotype in liver phosphorylase kinase deficiency with variants in the phosphorylase kinase (PHKG2) gene.
Liver Neoplasms
Phosphorylase Kinase ? Represents a Novel Prognostic Biomarker and Inhibits Malignant Phenotypes of Liver Cancer Cell.
Melanoma
Preliminary Study: Proteomic Profiling Uncovers Potential Proteins for Biomonitoring Equine Melanocytic Neoplasm.
Muscle Cramp
A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency.
Adult phosphorylase b kinase deficiency.
Muscle glycogenosis with low phosphorylase kinase activity: mutations in PHKA1, PHKG1 or six other candidate genes explain only a minority of cases.
Muscle Weakness
A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency.
Muscular Diseases
A female case of glycogen storage myopathy due to phosphorylase kinase deficiency.
A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency.
A splice junction mutation in the alpha(M) gene of phosphorylase kinase in a patient with myopathy.
Infantile glycogen storage myopathy in a girl with phosphorylase kinase deficiency.
Myopathy and phosphorylase kinase deficiency caused by a mutation in the PHKA1 gene.
Myopathy due to glycogen storage disease: pathological and biochemical studies in relation to glycogenosome formation.
Phosphorylase kinase activities in damaged mouse skeletal muscles.
Myalgia
A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency.
Myopathic evolution of an exertional muscle pain syndrome with phosphorylase b kinase deficiency.
Myoglobinuria
A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency.
Metabolic causes of myoglobinuria.
Metabolic myopathies.
Muscle glycogenosis with low phosphorylase kinase activity: mutations in PHKA1, PHKG1 or six other candidate genes explain only a minority of cases.
Neoplasms
An evaluation of indirubin analogues as phosphorylase kinase inhibitors.
Identification of phosphorylase kinase as a novel therapeutic target through high-throughput screening for anti-angiogenesis compounds in zebrafish.
KIAA1199 interacts with glycogen phosphorylase kinase ?-subunit (PHKB) to promote glycogen breakdown and cancer cell survival.
Urinary signatures of Renal Cell Carcinoma investigated by peptidomic approaches.
Pancreatitis, Acute Necrotizing
Evidence for the participation of proteases on protein catabolism during hypercatabolic renal failure.
Pancreatitis, Chronic
Evidence for the participation of proteases on protein catabolism during hypercatabolic renal failure.
phosphoglycerate kinase deficiency
Metabolic causes of myoglobinuria.
phosphoglycerate mutase deficiency
Metabolic causes of myoglobinuria.
phosphorylase kinase deficiency
A female case of glycogen storage myopathy due to phosphorylase kinase deficiency.
Adult phosphorylase b kinase deficiency.
Adult-onset exercise intolerance due to phosphorylase b kinase deficiency.
Alkalinization of phosphorylase kinase-deficient muscle during tetanic contraction.
Autosomal glycogenosis of liver and muscle due to phosphorylase kinase deficiency is caused by mutations in the phosphorylase kinase beta subunit (PHKB).
Autosomal recessive liver phosphorylase kinase deficiency caused by a novel splice-site mutation in the gene encoding the liver gamma subunit (PHKG2).
Autosomal recessive phosphorylase kinase deficiency in liver, caused by mutations in the gene encoding the beta subunit (PHKB).
Biochemical characteristics and increased tetraglucoside excretion in patients with phosphorylase kinase deficiency.
Biochemical diagnosis of hepatic glycogen storage diseases: 20 years French experience.
cDNA cloning of a liver isoform of the phosphorylase kinase alpha subunit and mapping of the gene to Xp22.2-p22.1, the region of human X-linked liver glycogenosis.
Characterization of the phosphorylase b to a converting activity in skeletal muscle extracts of mice with the phosphorylase b kinase deficiency mutation.
Clinical and biochemical features of 10 adult patients with muscle phosphorylase kinase deficiency.
Clinical and laboratory observations in a child with hepatic phosphorylase kinase deficiency.
Clinical and Molecular Variability in Patients with PHKA2 Variants and Liver Phosphorylase b Kinase Deficiency.
Common mutation in the PHKA2 gene with variable phenotype in patients with liver phosphorylase b kinase deficiency.
Comparison of the mechanism of isoproterenol-stimulated glycogenolysis in skeletal muscle of normal and phosphorylase kinase-deficient mice (I strain).
Detection of glycogen in a glycogen storage disease by 13C nuclear magnetic resonance.
Detection of PHKA2 gene mutation in four Japanese patients with hepatic phosphorylase kinase deficiency.
Dinucleotide repeat polymorphism within the PHKA1 gene at Xq12-q13.
Enzymatic analysis in lymphocytes and erythrocytes from six patients with different phenotypes of phosphorylase kinase deficiency.
Factor XI and phosphorylase b kinase deficiency.
Families with X-linked liver glycogenosis due to phosphorylase kinase deficiency.
Fanconi's syndrome with hepatorenal glycogenosis associated with phosphorylase b kinase deficiency.
Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency.
Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase.
Fatal infantile cardiopathy caused by phosphorylase b kinase deficiency.
Fetal bradycardia at 28 weeks of gestation associated with cardiac glycogen phosphorylase b kinase deficiency.
Fueling around with glycogen: the implications of muscle phosphorylase b kinase deficiency.
Genetic deficiencies of the glycogen phosphorylase system.
Glucose homeostasis during the perinatal period in normal rats and rats with a glycogen storage disorder.
Glycogen phosphorylase and its converter enzymes in haemolysates of normal human subjects and of patients with type VI glycogen-storage disease. A study of phosphorylase kinase deficiency.
Glycogen phosphorylase b kinase deficiency in three siblings.
Glycogen phosphorylase kinase deficiency: a survey of enzymes in phosphorylase activating system.
Glycogen storage disease type IX: benign glycogenosis of liver and hepatic phosphorylase kinase deficiency.
Glycogen storage disease. Studies related to the mechanism of glycogenosome formation.
Glycogen storage disease: clinical, biochemical, and molecular heterogeneity.
Glycogen-storage disease associated with phosphorylase kinase deficiency: evidence for X inactivation.
Glycogenolysis in liver of phosphorylase kinase-deficient rats during liver perfusion and ischaemia.
Glycogenosis due to liver and muscle phosphorylase kinase deficiency.
Hepatic phosphorylase b kinase deficiency with normal enzyme activity in erythrocytes and muscle.
Hepatic phosphorylase b kinase deficiency with normal enzyme activity in leukocytes and erythrocytes.
Hepatic phosphorylase b kinase deficiency with normal enzyme activity in leukocytes.
Hepatic phosphorylase kinase deficiency: a survey of phosphorylase kinase activity in erythrocytes.
Human muscle glycogenosis due to phosphorylase kinase deficiency associated with a nonsense mutation in the muscle isoform of the alpha subunit.
I/Lyn mouse phosphorylase kinase deficiency: mutation disrupts expression of the alpha/alpha'-subunit mRNAs.
In situ 13C NMR quantification of hepatic glycogen.
Infantile glycogen storage myopathy in a girl with phosphorylase kinase deficiency.
Infantile hypertrophic cardiomyopathy of glycogenosis type IX: isolated cardiac phosphorylase kinase deficiency.
Isolation and sequence analysis of a cDNA clone encoding the entire catalytic subunit of phosphorylase kinase.
Isolation of cDNA encoding the human liver phosphorylase kinase alpha subunit (PHKA2) and identification of a missense mutation of the PHKA2 gene in a family with liver phosphorylase kinase deficiency.
Liver glycogenosis and phosphorylase kinase deficiency.
Liver glycogenosis caused by a defective phosphorylase system: hemolysate analysis.
Liver glycogenosis due to phosphorylase kinase deficiency: PHKG2 gene structure and mutations associated with cirrhosis.
Localisation of the gene encoding the catalytic gamma subunit of phosphorylase kinase to human chromosome bands 7p12-q21.
Localization of a new type of X-linked liver glycogenosis to the chromosomal region Xp22 containing the liver alpha-subunit of phosphorylase kinase (PHKA2).
Lymphocyte phosphorylase kinase activities in the sex-linked form of liver phosphorylase kinase deficiency.
Mapping of the gene for X-linked liver glycogenosis due to phosphorylase kinase deficiency to human chromosome region Xp22.
Mapping of the phosphorylase kinase alpha subunit gene on the mouse X chromosome.
Metabolic adaptation in phosphorylase kinase deficiency. Changes in metabolite concentrations during tetanic stimulation of mouse leg muscles.
Metabolic causes of myoglobinuria.
Metabolic causes of recurrent rhabdomyolysis.
Molecular genetics of phosphorylase kinase: cDNA cloning, chromosomal mapping and isoform structure.
Muscle phosphorylase b kinase deficiency revisited.
Muscle phosphorylase kinase deficiency: a neutral metabolic variant or a disease?
Mutation hotspots in the PHKA2 gene in X-linked liver glycogenosis due to phosphorylase kinase deficiency with atypical activity in blood cells (XLG2).
Mutational analyses in four Japanese families with X-linked liver phosphorylase kinase deficiency type 1.
Myopathic evolution of an exertional muscle pain syndrome with phosphorylase b kinase deficiency.
Myopathy and phosphorylase kinase deficiency caused by a mutation in the PHKA1 gene.
Myopathy due to glycogen storage disease: pathological and biochemical studies in relation to glycogenosome formation.
Neonatal-onset severe recurrent hypoglycaemia in an infant with hepatic phosphorylase kinase deficiency with normal enzyme activity in erythrocytes.
No effect of oral sucrose or IV glucose during exercise in phosphorylase b kinase deficiency.
Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form.
PHKA2 variants expand the phenotype of phosphorylase B kinase deficiency to include patients with ketotic hypoglycemia only.
Phosphorylase b kinase deficiency glycogenosis with cirrhosis of the liver.
Phosphorylase b kinase deficiency in a boy with glycogenosis affecting both liver and muscle.
Phosphorylase b kinase deficiency in glycogenosis type VIII: differentiation of different phenotypes and heterozygotes by erythrocyte enzyme assay.
Phosphorylase b kinase deficiency in man: a review.
Phosphorylase kinase deficiency and decreased fat accumulation in hybrid male mice (I X C3H).
Phosphorylase kinase deficiency in I-strain mice is associated with a frameshift mutation in the alpha subunit muscle isoform.
Phosphorylase kinase deficiency in mice.
Phosphorylase kinase deficiency.
Phosphorylase kinase deficiency: severe glycogen storage disease with evidence of autosomal recessive mode of inheritance.
Severe phenotype of phosphorylase kinase-deficient liver glycogenosis with mutations in the PHKG2 gene.
Skeletal muscle glycogen content, structure, and metabolism are normal in rats with hepatic glycogen phosphorylase kinase deficiency.
Skeletal muscle phosphorylase kinase deficiency: detection of a protein lacking any activity in ICR-IAn mice.
Stimulation of glycogenolysis by beta adrenergic agonists in skeletal muscle of mice with the phosphorylase kinase deficiency mutation (I strain).
Substrate kinetics in patients with disorders of skeletal muscle metabolism.
The autosomal form of phosphorylase kinase deficiency in man: reduced activity of the muscle enzyme.
The effect of ethanol on glucose production in phosphorylase b kinase deficiency.
The molecular basis of skeletal muscle phosphorylase kinase deficiency.
The natural history of liver glycogenosis due to phosphorylase kinase deficiency: a longitudinal study of 41 patients.
The phosphorylase kinase activity of hearts from phosphorylase kinase-deficient mice.
The phosphorylase kinase deficiency (Phk) locus in the mouse: evidence that the mutant allele codes for an enzyme with an abnormal structure.
The phosphorylation of troponin B by phosphorylase b kinase in skeletal muscle of mice carrying the phosphorylase b kinase deficiency gene.
Uncooked cornstarch treatment for hepatic phosphorylase kinase deficiency.
Unequal homologous recombination between LINE-1 elements as a mutational mechanism in human genetic disease.
Use of platelets, mononuclear and polymorphonuclear cells in the diagnosis of glycogen storage disease type VI.
Variability of clinical and biochemical phenotype in liver phosphorylase kinase deficiency with variants in the phosphorylase kinase (PHKG2) gene.
Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene.
X-chromosomal inheritance of liver glycogenosis with phosphorylase kinase deficiency.
X-linked dominant inheritance of partial phosphorylase kinase deficiency in mice.
X-linked liver phosphorylase kinase deficiency is associated with mutations in the human liver phosphorylase kinase alpha subunit.
[Exercise intolerance caused by muscular phosphorylase kinase deficiency. Contribution of in vivo metabolic studies]
[Five cases of phosphorylase b kinase deficiency affecting muscle or liver: clinical symptoms and diagnosis]
[Glycogenesis due to adult phosphorylase kinase deficiency]
[Molecular pathology of hepatic glycogen storage disease]
[Phosphorylase b kinase deficiency]
[Regulation of glycogen metabolism in the liver and hepatic glycogenosis due to phosphorylase system deficiency]
Psoriasis
An evaluation of indirubin analogues as phosphorylase kinase inhibitors.
Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters.
Elevated phosphorylase kinase activity in psoriatic epidermis: correlation with increased phosphorylation and psoriatic activity.
pullulanase deficiency
The molecular background of glycogen metabolism disorders.
Renal Insufficiency
Evidence for the participation of proteases on protein catabolism during hypercatabolic renal failure.
Proteolytic activity in patients with hypercatabolic renal failure.
Respiratory Insufficiency
In vitro inhibition of protein catabolism by alpha 2-macroglobulin in plasma from a patient with posttraumatic acute renal failure.
Starvation
Effect of starvation on glycogen and glucose metabolism in different areas of the rat brain.
Starvation of phosphorylase kinase deficient rats is accompanied by partial hepatic glycogen depletion.
The association of phosphorylase kinase with membranes of rat liver smooth endoplasmic reticulum.
Uremia
Role of proteases in hypercatabolic patients with renal failure.
Whooping Cough
Synthetic peptides based on the calmodulin-binding domain of myosin light chain kinase inhibit activation of other calmodulin-dependent enzymes.